BioCentury
ARTICLE | Clinical News

Welchol colesevelam regulatory update

August 1, 2011 7:00 AM UTC

FDA approved an sNDA from Daiichi for an oral suspension formulation of Welchol colesevelam to be mixed with fruit juice or diet soft drinks to reduce elevated low-density lipoprotein cholesterol (LDL...